价格

LABORATORIOS FARMACEUTICOS ROVI SA

CALLE JULIAN CAMARILLO 35, Madrid, 西班牙www.rovi.es/en1,419 名员工成立于: 1946-01-0144亿美元

别名:

laboratorios farmaceuticos rovi

rovifarma

概览

试验阶段分布

阶段

试验数

占比

1 期

66.7%

3 期

33.3%

试验状态分布

招募中

100.0%

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

药物批准

EMA

European Medicines Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

114

药物批准

近期批准

ROLCYA 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2025-07-22

TRYPTIZOL 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2025-07-14

POLARAMINE 0,4 mg/ml JARABE

CIMA_AEMPS

2025-07-14

TRYPTIZOL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2025-07-14

EUFILINA VENOSA 200 mg SOLUCIÓN INYECTABLE

CIMA_AEMPS

2025-07-14

POLARACREM 2 mg/g + 5 mg/g CREMA

CIMA_AEMPS

2025-07-14

POLARAMINE 2 mg COMPRIMIDOS

CIMA_AEMPS

2025-07-14

POLARAMINE 5 mg/ml SOLUCION INYECTABLE

CIMA_AEMPS

2025-07-14

APIXABAN ROVI 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2025-07-03

APIXABAN ROVI 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

CIMA_AEMPS

2025-07-03

资讯

暂无资讯文章

返回机构列表

LABORATORIOS FARMACEUTICOS ROVI SA

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（3）

A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared with Femara® (both Combined with the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women with HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer (SIE-3)

SIE-1

A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women.

药物批准

按机构分类的批准

近期批准

资讯